Dacarbazine [clinicaltrials_resource:37c49b41e6d7ec8e69b465d742f8ffdc]
clinicaltrials:NCT00004259clinicaltrials:NCT00005037clinicaltrials:NCT00005812clinicaltrials:NCT00022711clinicaltrials:NCT00026494clinicaltrials:NCT00033280Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [clinicaltrials:NCT00039494]clinicaltrials:NCT00050986clinicaltrials:NCT00068250clinicaltrials:NCT00068666Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma [clinicaltrials:NCT00072163]clinicaltrials:NCT00077207Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00077454]clinicaltrials:NCT00080938Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00085254]clinicaltrials:NCT00091572clinicaltrials:NCT00098865clinicaltrials:NCT00100802clinicaltrials:NCT00104988clinicaltrials:NCT00112502clinicaltrials:NCT00114140clinicaltrials:NCT00182819Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer [clinicaltrials:NCT00194766]clinicaltrials:NCT00200161Combination Paclitaxel, Carboplatin and Temozolomide [clinicaltrials:NCT00249964]CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy [clinicaltrials:NCT00257205]clinicaltrials:NCT00266812Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [clinicaltrials:NCT00268385]clinicaltrials:NCT00275002clinicaltrials:NCT00275067clinicaltrials:NCT00304031clinicaltrials:NCT00305864clinicaltrials:NCT00311584clinicaltrials:NCT00313729Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00316849]clinicaltrials:NCT00362817clinicaltrials:NCT00365222clinicaltrials:NCT00389090The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601AM1)(COMPLETED) [clinicaltrials:NCT00392171]AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00394628]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Dacarbazine [clinicaltrials_resource:37c49b41e6d7ec8e69b465d742f8ffdc]
Bio2RDF identifier
37c49b41e6d7ec8e69b465d742f8ffdc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:37c49b41e6d7ec8e69b465d742f8ffdc
identifier
clinicaltrials_resource:37c49b41e6d7ec8e69b465d742f8ffdc
title
Dacarbazine
@en
type
label
Dacarbazine [clinicaltrials_resource:37c49b41e6d7ec8e69b465d742f8ffdc]
@en